# US 2009/0275754 A1 · Narcotine Purification Process

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0275754 A1
- Document ID: US20090275754A1
- Status: Published application
- Kind: A1
- Application number: 12/296,435
- Filed: 2007-03-28
- Published: 2009-11-05
- Earliest claimed: 2006-04-11
- Inventors: Keith G. Tomazi; Leroy Love, JR.; Joseph P. Haar, JR.
- Web page: https://patentgrep.com/patent/US20090275754A1

## CPC

- C07D 473/04: two oxygen atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

A process for purifying Narcotine to remove color and impurities to form Noscapine. The process includes forming an aqueous isopropanol solution with the Narcotine product wherein the isopropanol concentration of the solution is about 20% to about 70% by volume; and adjusting the pH of the solution with a strong base to a pH of about 10 to about 14, wherein impurities are removed from the Narcotine product.

## Claims

### Claim 1

A process for the removal of impurities from a Narcotine product comprising:
(a) forming a suspension of an aqueous isopropanol solution and the Narcotine product, wherein the isopropanol concentration of the solution is about 20% to about 70% by volume; and
(b) adjusting the pH of the suspension with a strong base to a pH of about 10 to about 14, wherein impurities are removed from the Narcotine product.

### Claim 2 (depends on 1)

The process of claim 1 further comprising stirring the suspension for at least 15 minutes after adjusting the pH.

### Claim 3 (depends on 2)

The process of claim 2 wherein the suspension is stirred at a temperature from about 18° C. to about 25° C.

### Claim 4 (depends on 1)

The process of claim 1 further comprising filtering the suspension to separate the impurities from the Narcotine product.

### Claim 5 (depends on 3)

The process of claim 3 further comprising filtering the suspension to separate the impurities from the Narcotine product.

### Claim 6 (depends on 1)

The process of claim 1 further comprising centrifuging the suspension to separate the impurities from the Narcotine product.

### Claim 7 (depends on 4)

The process of claim 4 further comprising washing the filtered suspension with the aqueous isopropanol solution.

### Claim 8 (depends on 5)

The process of claim 5 further comprising washing the filtered suspension with the aqueous isopropanol solution.

### Claim 9 (depends on 1)

The process of claim 1 wherein the isopropanol concentration of the solution is about 30% to about 60% by volume.

### Claim 10 (depends on 1)

The process of claim 1 wherein the isopropanol concentration of the solution is about 30% to about 50% by volume.

### Claim 11 (depends on 1)

The process of claim 1 wherein the strong base is selected from the group consisting of sodium hydroxide, potassium hydroxide, calcium hydroxide, calcium oxide, sodium carbonate, potassium carbonate, or solutions or mixtures thereof.

### Claim 12 (depends on 1)

The process of claim 1 wherein the strong base comprises sodium hydroxide.

### Claim 13 (depends on 12)

The process of claim 12 wherein the strong base comprises a 50% sodium hydroxide solution.

### Claim 14 (depends on 12)

The process of claim 12 wherein the strong base comprises a 25% sodium hydroxide solution.

### Claim 15 (depends on 1)

The process of claim 1 wherein the aqueous solution is adjusted to a pH of about 12 to about 13.

### Claim 16 (depends on 1)

The process of claim 1 wherein the Narcotine product is present in the suspension in an amount of from about 30 to about 40 grams per 100 ml aqueous isopropanol solution.

### Claim 17 (depends on 1)

The process of claim 1 wherein at least 90% of impurities are removed from the Narcotine.

### Claim 18 (depends on 1)

The process of claim 1 wherein at least 95% of impurities are removed from the Narcotine.

### Claim 19 (depends on 1)

The process of claim 1 wherein at least about 90% of Papaverine and Thebaine are removed from the Narcotine.

### Claim 20 (depends on 1)

The process of claim 1 wherein at least about 95% of Papaverine and Thebaine are removed from the Narcotine.

### Claim 21 (depends on 1)

The process of claim 1 wherein at least 90% of color is removed from the Narcotine.

### Claim 22 (depends on 1)

The process of claim 1 wherein at least 95% of color is removed from the Narcotine.

### Claim 23 (depends on 1)

The process of claim 1 wherein at least 85% of Noscapine Analog is removed from the Narcotine.

### Claim 24 (depends on 5)

The process of claim 5 further comprising treating the Narcotine product with activated carbon.

### Claim 25 (depends on 24)

The process of claim 24 further comprising precipitating the Narcotine product with ammonium hydroxide in isopropanol and water.
